OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cost-effectiveness analysis of cemiplimab vs pembrolizumab for treatment of advanced cutaneous squamous cell carcinoma
E. Paul, Gerasimos Konidaris, Shannon Cope, et al.
Journal of Managed Care & Specialty Pharmacy (2021) Vol. 27, Iss. 11, pp. 1513-1525
Open Access | Times Cited: 6
E. Paul, Gerasimos Konidaris, Shannon Cope, et al.
Journal of Managed Care & Specialty Pharmacy (2021) Vol. 27, Iss. 11, pp. 1513-1525
Open Access | Times Cited: 6
Showing 6 citing articles:
Whether and How Disutilities of Adverse Events were Used in the Economic Evaluation of Drug Therapy for Cancer Treatment
Yuqiong Lu, Zhanjing Dai, Feng Chang, et al.
PharmacoEconomics (2023) Vol. 41, Iss. 3, pp. 295-306
Open Access | Times Cited: 11
Yuqiong Lu, Zhanjing Dai, Feng Chang, et al.
PharmacoEconomics (2023) Vol. 41, Iss. 3, pp. 295-306
Open Access | Times Cited: 11
Cost-effectiveness of cemiplimab plus chemotherapy vs pembrolizumab plus chemotherapy as first-line treatment for advanced non–small cell lung cancer
Xiangzhong Xue, Surachat Ngorsuraches, Brandon Johnson, et al.
Journal of Managed Care & Specialty Pharmacy (2025) Vol. 31, Iss. 2, pp. 137-146
Closed Access
Xiangzhong Xue, Surachat Ngorsuraches, Brandon Johnson, et al.
Journal of Managed Care & Specialty Pharmacy (2025) Vol. 31, Iss. 2, pp. 137-146
Closed Access
Review of sociodemographic risk factors for presentation with advanced non-melanoma skin cancer
Colin Bacorn, Melissa Serrano, Lily Koo Lin
Orbit (2022) Vol. 42, Iss. 5, pp. 481-486
Closed Access | Times Cited: 7
Colin Bacorn, Melissa Serrano, Lily Koo Lin
Orbit (2022) Vol. 42, Iss. 5, pp. 481-486
Closed Access | Times Cited: 7
Duration of treatment with cemiplimab in advanced cutaneous squamous cell carcinoma in complete response: Real‐life study
K. Khelef, E. Maubec, G. Jeudy, et al.
Journal of the European Academy of Dermatology and Venereology (2023) Vol. 38, Iss. 1
Closed Access | Times Cited: 1
K. Khelef, E. Maubec, G. Jeudy, et al.
Journal of the European Academy of Dermatology and Venereology (2023) Vol. 38, Iss. 1
Closed Access | Times Cited: 1
T‐box transcription factor 2 mediates antitumor immune response in cutaneous squamous cell carcinoma by regulating the expression of programmed death ligand 1
Xu Wang, Zhi Li, Yadi Sun
Skin Research and Technology (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 2
Xu Wang, Zhi Li, Yadi Sun
Skin Research and Technology (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 2
Bilateral primary squamous cell carcinoma of the conjunctiva
Nishaant Bhambra, Bryan Arthurs, Sabrina Bergeron, et al.
Canadian Journal of Ophthalmology (2022) Vol. 57, Iss. 6, pp. e210-e213
Closed Access
Nishaant Bhambra, Bryan Arthurs, Sabrina Bergeron, et al.
Canadian Journal of Ophthalmology (2022) Vol. 57, Iss. 6, pp. e210-e213
Closed Access
